The story of Eli Lilly and Novo Nordisk’s GLP-1 dominance is likely to play out again in 2025 as the metabolic medicine ...

Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research are set to play out.

Alliance Pharma said it agreed to a 349.7 million pound ($430.4 million) takeover by its largest shareholder DBAY Advisors.

America's largest pharmacy chains are having a tough time competing with Amazon, and it isn't primarily because of medicine ...

If you're too busy to keep monitoring your stock portfolio every other day, then investing in stocks that won't cause you a ...

Themed on ‘Building a Culture of Innovation and Technology in Healthcare’, the three-day event will spotlight medical ...

The plaintiffs argue federal law lets employers structure medicine benefits in ways the 2019 state law threatens.

HERZLIYA, Israel and CALGARY, Alberta, Jan. 9, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical ...